<DOC>
	<DOCNO>NCT02042014</DOCNO>
	<brief_summary>To provide continued treatment Pulmonary Arterial Hypertension ( PAH ) patient benefit treatment QTI571 .</brief_summary>
	<brief_title>Open-label , Multi-center Protocol Provide QTI571 PAH Patients Who Participated Extension Study ( A2301E1 ) Japan</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>patient receive QTI571 treatment Pulmonary Arterial Hypertension ( PAH ) currectly enrol longterm extension study ( CQTI571A2301E1 ) Japan . Patient currently benifitting form treatment QTI571 opinion investigator . Patient permanently discontinue QTI571 study treatment parent study . Concomitant use oral vitamin K antagonist medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pulmonary arterial hypertension , QTI571 , open label study</keyword>
</DOC>